Longstaff Holly, Lucas Brenda, Schichter Brittney, Murthy Srinivas, Flamenbaum Jaime
BC Provincial Health Services Authority (Longstaff, Schichter); University of British Columbia Children's and Women's Health Centre of British Columbia Research Ethics Board (Longstaff), Vancouver, BC; Canadian Critical Care Trials Group (Lucas), Markham, Ont.; Faculty of Medicine (Murthy), University of British Columbia, Vancouver, BC; Science Policy Branch (Flamenbaum), Canadian Institutes of Health Research, Ottawa, Ont.
CMAJ. 2025 Sep 14;197(30):E941-E952. doi: 10.1503/cmaj.250500.
Consent forms have become too long and often do little to help people understand the risk elements of their participation in research, instead focusing on risk reduction for research institutions. Under the auspices of the Canadian Institutes of Health Research and the Canadian Critical Care Trials Group, we identified a core set of elements for participant consent documents to be used in clinical research and present these as a template consent form.
Our guideline core team comprised experts in the legal and ethical aspects of research, and a clinical trialist-scientist. We conducted a directed review to compile a list of applicable regulatory, policy, and guidance requirements for the documentation of informed consent for research conducted with human participants in Canada. We used a gap analysis to identify the elements required in a research consent form, based on these documents and in comparison with 10 existing research ethics board (REB) informed-consent form templates. The guideline, as well as a fillable template for the form, was created with input from a pan-Canadian advisory group, interested parties, and broad public input. We tested the template with a small group of studies across several research domains. Our process for managing competing interests adhered to Guidelines International Network principles.
From our gap analysis, we identified 75 core elements for participant consent forms in clinical research, which we have grouped under 6 main categories (i.e., information for potential participants about participating in research in general and in the particular study; harms and benefits of participation; protection of participant data; points of contact; and giving consent) in a fillable consent template. Because studies vary, specific elements should be included in a study consent form only if relevant to the type of research being conducted and the corresponding compliance requirements, as identified in our gap analysis.
The template with the core set of required elements is intended to be used by any researcher applying for REB approval to document participant consent and, when applied with consideration of our associated guidance, is sufficient to meet regulatory requirements for research in Canada. Identifying the required elements for consent forms is intended to streamline consent documents across the country, facilitate multi-site projects, and simplify the approval process for all those involved.
同意书变得过于冗长,往往无助于人们理解参与研究的风险因素,反而侧重于为研究机构降低风险。在加拿大卫生研究院和加拿大重症监护试验组的支持下,我们确定了一套用于临床研究参与者同意文件的核心要素,并将其作为同意书模板呈现。
我们的指南核心团队由研究的法律和伦理方面的专家以及一名临床试验科学家组成。我们进行了定向审查,以编制加拿大针对涉及人类参与者的研究的知情同意文件记录的适用监管、政策和指导要求清单。我们通过差距分析,根据这些文件并与10个现有的研究伦理委员会(REB)知情同意书模板进行比较,确定研究同意书中所需的要素。该指南以及该表格的可填写模板是在泛加拿大咨询小组、相关方的意见以及广泛的公众意见的基础上创建的。我们在几个研究领域的一小部分研究中测试了该模板。我们管理利益冲突的过程遵循国际准则网络原则。
通过差距分析,我们确定了临床研究参与者同意书的75个核心要素,我们将其归为6个主要类别(即关于一般参与研究和特定研究的潜在参与者信息;参与的危害和益处;参与者数据的保护;联系点;以及给予同意),并放入一个可填写的同意模板中。由于研究各不相同,只有与正在进行的研究类型及相应的合规要求相关时,才应在研究同意书中包含特定要素,这是我们在差距分析中确定的。
包含所需核心要素的模板旨在供任何申请REB批准的研究人员用于记录参与者同意,并且在结合我们的相关指导意见应用时,足以满足加拿大研究的监管要求。确定同意书的所需要素旨在简化全国范围内的同意文件,促进多中心项目,并简化所有相关方的审批流程。